Effects of Bile Salts on Gastrointestinal Absorption of Pravastatin

被引:9
作者
Chun, In Koo [3 ]
Lee, Kyung Min [3 ]
Lee, Kyung Eun [1 ,2 ]
Gwak, Hye Sun [1 ,2 ]
机构
[1] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea
[2] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea
[3] Dongduk Womens Univ, Coll Pharm, Seoul 501759, South Korea
关键词
pravastatin; solid dispersions; bile salts; gastrointestinal absorption; dissolution; INTESTINAL-ABSORPTION; REDUCTASE INHIBITORS; SODIUM CAPRATE; RELEASE; TAUROCHOLATE; SURFACTANTS; DRUG;
D O I
10.1002/jps.23123
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This study aimed to examine the effects of bile salts and formulations on the absorption through gastrointestinal tract of pravastatin, which has low bioavailability. Pravastatin sodium physical mixtures and solid dispersions were prepared using various bile salts. The physicochemical characteristics and permeation profiles were investigated using pravastatin sodium-bile salt physical mixtures and solid dispersions. Pravastatin in the physical mixture did not achieve amorphous state, whereas that in the solid dispersion was completely converted to amorphous state. The permeation enhancement factors ranged between 1.13 and 11.9 with the addition of bile salts, and the permeation flux of pravastatin sodium greatly increased as the sodium cholate (NaC) concentration increased from 5 to 10 mM. Pravastatin sodium permeation fluxes [mu g/(cm(2) h)] from solid dispersions (drug-NaC = 1:49) (20.8 +/- 2.7) were much higher than those from physical mixtures (4.7 +/- 3.1) and commercial tablets (3.5 +/- 1.2) (p < 0.05). The dissolution rates of pravastatin sodium from solid dispersions in pH 1.2 were much lower than those from physical mixtures and commercial products, whereas more than 97% of pravastatin sodium was dissolved at 5 min in pH 6.8. On the basis of the results, it was concluded that pravastatin sodium solid dispersions containing bile salts could enhance drug absorption. (C) 2012 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 101:2281-2287, 2012
引用
收藏
页码:2281 / 2287
页数:7
相关论文
共 21 条
[1]   Differential interaction of 3-hydroxy-3-methylglutaryl-COA reductase inhibitors with ABCB1, ABCC2, and OATP1B1 [J].
Chen, CP ;
Mireles, RJ ;
Campbell, SD ;
Lin, J ;
Mills, JB ;
Xu, JHJ ;
Smolarek, TA .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (04) :537-546
[2]   New insights into the pharmacodynamic and pharmacokinetic properties of statins [J].
Corsini, A ;
Bellosta, S ;
Baetta, R ;
Fumagalli, R ;
Paoletti, R ;
Bernini, F .
PHARMACOLOGY & THERAPEUTICS, 1999, 84 (03) :413-428
[3]   REVERSAL OF MULTIDRUG-RESISTANCE PHENOTYPE BY SURFACTANTS - RELATIONSHIP TO MEMBRANE LIPID FLUIDITY [J].
DUDEJA, PK ;
ANDERSON, KM ;
HARRIS, JS ;
BUCKINGHAM, L ;
COON, JS .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 319 (01) :309-315
[4]  
KAKEMI K, 1970, CHEM PHARM BULL, V18, P275
[5]  
KIMURA T, 1972, CHEM PHARM BULL, V20, P1656
[6]   BIOTRANSFORMATION OF PRAVASTATIN SODIUM(I) - MECHANISMS OF ENZYMATIC TRANSFORMATION AND EPIMERIZATION OF AN ALLYLIC HYDROXY GROUP OF PRAVASTATIN SODIUM [J].
KITAZAWA, E ;
TAMURA, N ;
IWABUCHI, H ;
UCHIYAMA, M ;
MURAMATSU, S ;
TAKAHAGI, H ;
TANAKA, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 192 (02) :597-602
[7]   High-efficiency loading and controlled release of highly water-soluble drug, pravastatin sodium by use of crosslinked beta-cyclodextrin [J].
Kumar, Yatendra ;
Philip, Betty ;
Pathak, Kamla .
INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2011, 1 (01) :10-16
[8]   EFFECTS OF BILE-ACIDS ON MUCUS SECRETION IN THE DOG COLON [J].
LEWIN, MR ;
ELMASRI, SH ;
CLARK, CG .
EUROPEAN SURGICAL RESEARCH, 1979, 11 (06) :392-398
[9]   Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats [J].
Lo, YL ;
Huang, JD .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (06) :665-672
[10]   PRAVASTATIN - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL IN HYPERCHOLESTEROLEMIA [J].
MCTAVISH, D ;
SORKIN, EM .
DRUGS, 1991, 42 (01) :65-89